Hemrajani Rekha bought ALXO
January 20, 2026 · Form 4 insider transaction
Hemrajani Rekha bought 40,400 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
40,400
Price
$0.00
Total value
N/A
InsiderHemrajani Rekha
RoleDirector
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after40,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.